Welcome to Lantheus Medical Imaging
As a worldwide leader in diagnostic imaging for the past 55 years, we remain dedicated to creating and pioneering medical imaging solutions to improve the treatment of human disease. We are a leading specialty pharmaceutical company that develops, manufactures and distributes innovative diagnostic medical imaging products on a global basis. Our current imaging agents primarily assist in the diagnosis of heart, vascular and other diseases using nuclear imaging, echocardiography and magnetic resonance imaging (MRI) technologies. We also have full clinical and preclinical development pipeline of next-generation and first-in-class products that use Positron Emission Tomography (PET) and MRI technologies. With direct operations in the United States, Puerto Rico, Canada and Australia, we have a long and distinguished history of developing and commercializing innovative market-changing products.
|
|
Recent SEC Filings
Form 8-K dated November 14, 2011
Form 10-Q for the third quarter ended September 30, 2011
Form 10-Q for the third quarter ended September 30, 2011 (interactive data filing) XBRL Documents
Form 8-K dated August 17, 2011
Form 10-Q for the second quarter ended June 30, 2011
Form 10-Q for the second quarter ended June 30, 2011 (interactive data filing) XBRL Documents
Form 10-Q for the first quarter ended March 31, 2011
Form 8-K dated May 23, 2011
Form 10-K for the fiscal year ended December 31, 2010
Recent News
11/14/11
Lantheus Medical Imaging Announces Chief Financial Officer
Robert Gaffey to Retire
11/14/11
Lantheus Medical Imaging to Host Third Quarter 2011 Conference Call on November 21, 2011 at 4:00 p.m. Eastern Time
10/27/11
Lantheus Medical Imaging Announces Labeling Changes for DEFINITY®
|
|
Company Spotlight
 |
Webcast
Q3 2011 Lantheus Medical Earnings Conference Call (Live)
Monday, November 21, 2011 at 4:00 p.m. ET |
LANTHEUS MEDICAL IMAGING ANNOUNCES CHIEF FINANCIAL OFFICER
ROBERT GAFFEY TO RETIRE
JEFFREY YOUNG APPOINTED TO SUCCEED GAFFEY AS CFO
No. BILLERICA, Mass. (January 4, 2012) – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that Robert Gaffey, Chief Financial Officer, will retire from the Company after more than 37 years of service to the organization, effective January 3, 2012. Jeffrey Young, CPA, has been appointed to succeed Mr. Gaffey as Chief Financial Officer, effective January 3, 2012. As Chief Financial Officer, Mr. Young will direct the Company’s global financial strategy, as well as oversee investor relations and strategic corporate communications. Mr. Young will report to Don Kiepert, President and Chief Executive Officer of Lantheus.
click here for the press release |
